{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:27:23Z","timestamp":1787041643774,"version":"build-2736575974"},"reference-count":105,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ejmech.2026.119128","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T23:44:53Z","timestamp":1783467893000},"page":"119128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Small molecule NS4B inhibitors for the treatment of the family Flaviviridae infection: A medicinal chemistry perspective"],"prefix":"10.1016","volume":"317","author":[{"given":"Xuan","family":"Guan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weipeng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erkang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.119128_bib1","doi-asserted-by":"crossref","first-page":"12496","DOI":"10.1128\/JVI.01059-07","article-title":"Characterization of hepatitis C virus deletion mutants circulating in chronically infected patients","volume":"81","author":"Noppornpanth","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.ejmech.2026.119128_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2022.105423","article-title":"Flavivirus NS4B protein: structure, function, and antiviral discovery","volume":"207","author":"Wang","year":"2022","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2026.119128_bib3","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3390\/tropicalmed6040180","article-title":"Current trends and limitations in dengue antiviral research","volume":"6","author":"Obi","year":"2021","journal-title":"Trop. Med. Infect. Dis."},{"key":"10.1016\/j.ejmech.2026.119128_bib4","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.119128_bib5","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3390\/v17010074","article-title":"A comprehensive review of the development and therapeutic use of antivirals in Flavivirus infection","volume":"17","author":"Tripathi","year":"2025","journal-title":"Viruses"},{"key":"10.1016\/j.ejmech.2026.119128_bib6","article-title":"Dengue viruses \u2013 an overview","volume":"3","author":"Tuiskunen B\u00e4ck","year":"2013","journal-title":"Infect. Ecol. Epidemiol."},{"key":"10.1016\/j.ejmech.2026.119128_bib7","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.antiviral.2013.09.013","article-title":"Ten years of dengue drug discovery: progress and prospects","volume":"100","author":"Lim","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2026.119128_bib8","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.jhep.2020.08.018","article-title":"EASL recommendations on treatment of hepatitis C: final update of the series\u2606","volume":"73","author":"Pawlotsky","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejmech.2026.119128_bib9","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0140-6736(19)32320-7","article-title":"Hepatitis C","volume":"394","author":"Spearman","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2026.119128_bib10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1411037","article-title":"Efficacy of a tetravalent dengue vaccine in children in Latin America","volume":"372","author":"Villar","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2026.119128_bib11","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJMoa1506223","article-title":"Efficacy and long-term safety of a dengue vaccine in regions of endemic disease","volume":"373","author":"Hadinegoro","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2026.119128_bib12","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taaf023","article-title":"Vaccination perspectives: the Qdenga\u00ae dilemma","volume":"32","author":"Fletcher","year":"2025","journal-title":"J. Trav. Med."},{"key":"10.1016\/j.ejmech.2026.119128_bib13","article-title":"A comparison of sofosbuvir\/velpatasvir and glecaprevir\/pibrentasvir for the treatment of hepatitis C infection among people who inject drugs","volume":"10","author":"Yi","year":"2024","journal-title":"J. Virus Erad."},{"key":"10.1016\/j.ejmech.2026.119128_bib14","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.3390\/v15122430","article-title":"Cellular release of infectious hepatitis C virus particles via endosomal pathways","volume":"15","author":"Deng","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.ejmech.2026.119128_bib15","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bcp.2018.04.008","article-title":"Dengue virus NS2 and NS4: minor proteins, mammoth roles","volume":"154","author":"Gopala Reddy","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119128_bib16","doi-asserted-by":"crossref","first-page":"12068","DOI":"10.1002\/anie.201606609","article-title":"Secondary structure and membrane topology of the Full_Length dengue virus NS4B in micelles","volume":"55","author":"Li","year":"2016","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ejmech.2026.119128_bib17","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.virol.2013.08.006","article-title":"Protein\u2013protein interactions among west nile non-structural proteins and transmembrane complex formation in mammalian cells","volume":"446","author":"Yu","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.ejmech.2026.119128_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007736","article-title":"A novel interaction between dengue virus nonstructural protein 1 and the NS4A-2K-4B precursor is required for viral RNA replication but not for formation of the membranous replication organelle","volume":"15","author":"P\u0142aszczyca","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2026.119128_bib19","doi-asserted-by":"crossref","first-page":"7360","DOI":"10.1128\/JVI.00157-12","article-title":"Evidence for a genetic and physical interaction between nonstructural proteins NS1 and NS4B that modulates replication of West Nile virus","volume":"86","author":"Youn","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.ejmech.2026.119128_bib20","doi-asserted-by":"crossref","first-page":"11183","DOI":"10.1128\/JVI.05468-11","article-title":"Inhibition of dengue virus by targeting viral NS4B protein","volume":"85","author":"Xie","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.ejmech.2026.119128_bib21","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/rmv.640","article-title":"Hepatitis C virus nonstructural protein 4B: a journey into unexplored territory","volume":"20","author":"Gouttenoire","year":"2010","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.ejmech.2026.119128_bib22","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1099\/vir.0.82211-0","article-title":"Dual topology of the processed hepatitis C virus protein NS4B is influenced by the NS5A protein","volume":"87","author":"Lundin","year":"2006","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.ejmech.2026.119128_bib23","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1016\/j.bbamem.2015.09.016","article-title":"Secondary structure and membrane topology of dengue virus NS4B N-terminal 125 amino acids","volume":"1848","author":"Li","year":"2015","journal-title":"Biochim. Biophys. Acta BBA - Biomembr."},{"key":"10.1016\/j.ejmech.2026.119128_bib24","doi-asserted-by":"crossref","first-page":"8854","DOI":"10.1074\/jbc.M512697200","article-title":"Subcellular localization and membrane topology of the dengue virus type 2 non-structural protein 4B","volume":"281","author":"Miller","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.119128_bib25","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1099\/vir.0.81844-0","article-title":"Dengue virus NS4B interacts with NS3 and dissociates it from single-stranded RNA","volume":"87","author":"Umareddy","year":"2006","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.ejmech.2026.119128_bib26","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3390\/v4030397","article-title":"Innate immunity evasion by dengue virus","volume":"4","author":"Morrison","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.ejmech.2026.119128_bib27","article-title":"Hepatitis C virus NS4B induces the degradation of TRIF to inhibit TLR3-mediated interferon signaling pathway","volume":"14","author":"Liang","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2026.119128_bib28","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.antiviral.2017.10.011","article-title":"Characterization of a dengue NS4B inhibitor originating from an HCV small molecule library","volume":"147","author":"Hernandez-Morales","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2026.119128_bib29","doi-asserted-by":"crossref","first-page":"15ra6","DOI":"10.1126\/scitranslmed.3000331","article-title":"Identification of a class of HCV inhibitors directed against the nonstructural protein NS4B","volume":"2","author":"Cho","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejmech.2026.119128_bib30","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1128\/AAC.00113-14","article-title":"Identification of AP80978, a novel small-molecule inhibitor of hepatitis C virus replication that targets NS4B","volume":"58","author":"Dufner-Beattie","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.119128_bib31","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/nbt.1490","article-title":"Discovery of a hepatitis C target and its pharmacological inhibitors by microfluidic affinity analysis","volume":"26","author":"Einav","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejmech.2026.119128_bib32","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1021\/jm401621g","article-title":"Structure\u2013activity relationship (SAR) optimization of 6-(Indol-2-yl)pyridine-3-sulfonamides: identification of potent, selective, and orally bioavailable small molecules targeting hepatitis C (HCV) NS4B","volume":"57","author":"Zhang","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119128_bib33","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1128\/AAC.00527-13","article-title":"Identification of PTC725, an orally bioavailable small molecule that selectively targets the hepatitis C virus NS4B protein","volume":"57","author":"Gu","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.119128_bib34","doi-asserted-by":"crossref","first-page":"7060","DOI":"10.1128\/AAC.01272-16","article-title":"PTC725, an NS4B-Targeting compound, inhibits a hepatitis C virus genotype 3 replicon, as predicted by genome sequence analysis and determined experimentally","volume":"60","author":"Graci","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.119128_bib35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.coviro.2020.07.009","article-title":"Recent advances in antiviral drug development towards dengue virus","volume":"43","author":"Troost","year":"2020","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.ejmech.2026.119128_bib36","doi-asserted-by":"crossref","DOI":"10.1136\/bmjph-2025-004043","article-title":"Dengue therapeutics consortium 2025: a global collaboration in action","volume":"4","author":"McBride","year":"2026","journal-title":"BMJ Public Health"},{"key":"10.1016\/j.ejmech.2026.119128_bib37","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.coviro.2012.12.001","article-title":"Flaviviruses: braking the entering","volume":"3","author":"Pierson","year":"2013","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.ejmech.2026.119128_bib38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.coviro.2019.01.005","article-title":"Strategies for Zika drug discovery","volume":"35","author":"Zou","year":"2019","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.ejmech.2026.119128_bib39","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/978-981-10-8727-1_9","article-title":"The dengue virus replication complex: from RNA replication to protein-protein interactions to evasion of innate immunity","volume":"1062","author":"Lescar","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ejmech.2026.119128_bib40","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3390\/membranes12020231","article-title":"Structures and dynamics of dengue virus nonstructural membrane proteins","volume":"12","author":"Li","year":"2022","journal-title":"Membranes"},{"key":"10.1016\/j.ejmech.2026.119128_bib41","doi-asserted-by":"crossref","first-page":"956","DOI":"10.3390\/v13060956","article-title":"Molecular insights into the flavivirus replication complex","volume":"13","author":"Van Den Elsen","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.ejmech.2026.119128_bib42","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cell.2020.12.005","article-title":"TMEM41B is a pan-flavivirus host factor","volume":"184","author":"Hoffmann","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2026.119128_bib43","doi-asserted-by":"crossref","first-page":"29","DOI":"10.7150\/ijms.3.29","article-title":"Molecular virology of Hepatitis C Virus (HCV): 2006 update","volume":"3","author":"Brass","year":"2006","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.ejmech.2026.119128_bib44","doi-asserted-by":"crossref","first-page":"5326","DOI":"10.1128\/JVI.76.11.5326-5338.2002","article-title":"Genetic analysis of sequences in the 3\u2032 nontranslated region of hepatitis C virus that are important for RNA replication","volume":"76","author":"Friebe","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.ejmech.2026.119128_bib45","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1128\/JVI.74.4.2046-2051.2000","article-title":"Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3\u2032 nontranslated region are essential for virus replication in vivo","volume":"74","author":"Kolykhalov","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.ejmech.2026.119128_bib46","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1073\/pnas.96.5.2291","article-title":"In vivo analysis of the 3\u2032 untranslated region of the hepatitis C virus after in vitro mutagenesis of an infectious cDNA clone","volume":"96","author":"Yanagi","year":"1999","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejmech.2026.119128_bib47","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.cell.2004.09.038","article-title":"The pathway of HCV IRES-mediated translation initiation","volume":"119","author":"Otto","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2026.119128_bib48","doi-asserted-by":"crossref","first-page":"12047","DOI":"10.1128\/JVI.75.24.12047-12057.2001","article-title":"Sequences in the 5\u2032 nontranslated region of hepatitis C virus required for RNA replication","volume":"75","author":"Friebe","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.ejmech.2026.119128_bib49","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1128\/jvi.67.6.3338-3344.1993","article-title":"Translation of human hepatitis C virus RNA in cultured cells is mediated by an internal ribosome-binding mechanism","volume":"67","author":"Wang","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.ejmech.2026.119128_bib50","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1128\/jvi.67.5.2832-2843.1993","article-title":"Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites","volume":"67","author":"Grakoui","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.ejmech.2026.119128_bib51","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/hep.24523","article-title":"Hepatitis C virus E1 envelope glycoprotein interacts with apolipoproteins in facilitating entry into hepatocytes","volume":"54","author":"Mazumdar","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.ejmech.2026.119128_bib52","doi-asserted-by":"crossref","first-page":"5063","DOI":"10.1128\/jvi.68.8.5063-5073.1994","article-title":"Processing in the hepatitis C virus E2-NS2 region: identification of p7 and two distinct E2-specific products with different C termini","volume":"68","author":"Lin","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.ejmech.2026.119128_bib53","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.virol.2014.10.027","article-title":"NS5B induces up-regulation of the BH3-only protein, BIK, essential for the hepatitis C virus RNA replication and viral release","volume":"474","author":"Aweya","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.ejmech.2026.119128_bib54","doi-asserted-by":"crossref","first-page":"22725","DOI":"10.1074\/jbc.R110.125294","article-title":"Hepatitis C virus non-structural protein 3 (HCV NS3): a multifunctional antiviral target","volume":"285","author":"Raney","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.119128_bib55","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.coviro.2013.03.013","article-title":"Structures of hepatitis C virus nonstructural proteins required for replicase assembly and function","volume":"3","author":"Gu","year":"2013","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.ejmech.2026.119128_bib56","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1128\/JVI.02052-13","article-title":"Hepatitis C virus RNA replication and virus particle assembly require specific dimerization of the NS4A protein transmembrane domain","volume":"88","author":"Kohlway","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.ejmech.2026.119128_bib57","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1128\/jvi.67.7.3835-3844.1993","article-title":"Nonstructural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3\/4 and NS4\/5 junctions","volume":"67","author":"Bartenschlager","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.ejmech.2026.119128_bib58","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.3390\/v12101069","article-title":"Solid-State NMR for studying the structure and dynamics of viral assemblies","volume":"12","author":"Lecoq","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.ejmech.2026.119128_bib59","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1128\/JVI.80.9.4623-4632.2006","article-title":"Regulated cleavages at the west nile virus NS4A-2K-NS4B junctions play a major role in rearranging cytoplasmic membranes and golgi trafficking of the NS4A protein","volume":"80","author":"Roosendaal","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.ejmech.2026.119128_bib60","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1128\/JVI.03453-14","article-title":"Characterization of dengue virus NS4A and NS4B protein interaction","volume":"89","author":"Zou","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.ejmech.2026.119128_bib61","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s11262-013-0956-5","article-title":"A hepatitis C virus NS4B inhibitor suppresses viral genome replication by disrupting NS4B's dimerization\/multimerization as well as its interaction with NS5A","volume":"47","author":"Choi","year":"2013","journal-title":"Virus Genes"},{"key":"10.1016\/j.ejmech.2026.119128_bib62","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jare.2024.12.041","article-title":"Protein palmitoylation in hepatic diseases: functional insights and therapeutic strategies","volume":"76","author":"Wang","year":"2025","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.ejmech.2026.119128_bib63","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1021\/jm400125h","article-title":"Hepatitis C replication inhibitors that target the viral NS4B protein","volume":"57","author":"Miller","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119128_bib64","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1021\/acs.jproteome.6b00933","article-title":"Systems biology reveals NS4B-Cyclophilin A interaction: a new target to inhibit YFV replication","volume":"16","author":"Vidotto","year":"2017","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.ejmech.2026.119128_bib65","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1128\/AAC.00189-09","article-title":"Cyclosporine inhibits flavivirus replication through blocking the interaction between host cyclophilins and viral NS5 protein","volume":"53","author":"Qing","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.119128_bib66","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.3390\/v13122448","article-title":"INMI1 Zika virus NS4B antagonizes the interferon signaling by suppressing STAT1 phosphorylation","volume":"13","author":"Fanunza","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.ejmech.2026.119128_bib67","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41586-023-05790-6","article-title":"Blocking NS3\u2013NS4B interaction inhibits dengue virus in non-human primates","volume":"615","author":"Goethals","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.119128_bib68","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/s41586-021-03990-6","article-title":"A pan-serotype dengue virus inhibitor targeting the NS3\u2013NS4B interaction","volume":"598","author":"Kaptein","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.119128_bib69","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00553-15","article-title":"Dengue virus NS proteins inhibit RIG-I\/MAVS signaling by blocking TBK1\/IRF3 phosphorylation: dengue virus serotype 1 NS4A is a unique interferon-regulating virulence determinant","volume":"6","author":"Dalrymple","year":"2015","journal-title":"mBio"},{"key":"10.1016\/j.ejmech.2026.119128_bib70","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00887-19","article-title":"Japanese encephalitis virus induces apoptosis and encephalitis by activating the PERK pathway","volume":"93","author":"Wang","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.ejmech.2026.119128_bib71","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1750-9378-7-7","article-title":"Innate immunity and hepatitis C virus infection: a microarray's view","volume":"7","author":"Buonaguro","year":"2012","journal-title":"Infect. Agents Cancer"},{"key":"10.1016\/j.ejmech.2026.119128_bib72","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13027-024-00606-2","article-title":"From viruses to cancer: exploring the role of the hepatitis C virus NS3 protein in carcinogenesis","volume":"19","author":"Martineau","year":"2024","journal-title":"Infect. Agents Cancer"},{"key":"10.1016\/j.ejmech.2026.119128_bib73","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.3390\/cancers13102485","article-title":"HCV proteins modulate the host cell miRNA expression contributing to hepatitis C pathogenesis and hepatocellular carcinoma development","volume":"13","author":"Pascut","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejmech.2026.119128_bib74","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/j.celrep.2019.04.051","article-title":"The ER membrane protein complex promotes biogenesis of dengue and Zika virus non-structural multi-pass transmembrane proteins to support infection","volume":"27","author":"Lin","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejmech.2026.119128_bib75","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00939-17","article-title":"Dengue virus hijacks a noncanonical oxidoreductase function of a cellular oligosaccharyltransferase complex","volume":"8","author":"Lin","year":"2017","journal-title":"mBio"},{"key":"10.1016\/j.ejmech.2026.119128_bib76","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/ncb2407","article-title":"Emerging functions of the VCP\/p97 AAA-ATPase in the ubiquitin system","volume":"14","author":"Meyer","year":"2012","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ejmech.2026.119128_bib77","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.3390\/v13102092","article-title":"The biogenesis of dengue virus replication organelles requires the ATPase activity of valosin-containing protein","volume":"13","author":"Mazeaud","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.ejmech.2026.119128_bib78","doi-asserted-by":"crossref","first-page":"7100","DOI":"10.1016\/j.vaccine.2015.09.108","article-title":"Development of the sanofi pasteur tetravalent dengue vaccine: one more step forward","volume":"33","author":"Guy","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.ejmech.2026.119128_bib79","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1080\/21645515.2019.1658503","article-title":"A review of dengvaxia\u00ae: development to deployment","volume":"15","author":"Thomas","year":"2019","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.ejmech.2026.119128_bib80","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/hep.22759","article-title":"Diagnosis, management, and treatment of hepatitis C: an update","volume":"49","author":"Ghany","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.ejmech.2026.119128_bib81","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2893.2008.01012.x","article-title":"Expert opinion on the treatment of patients with chronic hepatitis C","volume":"16","author":"Zeuzem","year":"2009","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.ejmech.2026.119128_bib82","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection","volume":"347","author":"Fried","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2026.119128_bib83","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1021\/acs.jmedchem.3c02336","article-title":"Discovery of JNJ-1802, a first-in-class pan-serotype dengue virus NS4B inhibitor","volume":"67","author":"Kesteleyn","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119128_bib84","doi-asserted-by":"crossref","first-page":"8390","DOI":"10.1021\/acs.jmedchem.8b00913","article-title":"Discovery of indole derivatives as novel and potent dengue virus inhibitors","volume":"61","author":"Bardiot","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119128_bib85","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.1016\/j.bmcl.2013.04.050","article-title":"Discovery of N-(4\u2032-(indol-2-yl)phenyl)sulfonamides as novel inhibitors of HCV replication","volume":"23","author":"Chen","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2026.119128_bib86","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1016\/j.bmcl.2013.04.049","article-title":"Discovery of novel HCV inhibitors: synthesis and biological activity of 6-(indol-2-yl)pyridine-3-sulfonamides targeting hepatitis C virus NS4B","volume":"23","author":"Zhang","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2026.119128_bib87","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.antiviral.2013.05.011","article-title":"Identification of a new dengue virus inhibitor that targets the viral NS4B protein and restricts genomic RNA replication","volume":"99","author":"Van Cleef","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2026.119128_bib88","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/cid\/ciad284","article-title":"Safety, tolerability, and pharmacokinetics of JNJ-1802, a pan-serotype dengue direct antiviral small molecule, in a phase 1, double-blind, randomized, dose-escalation study in healthy volunteers","volume":"77","author":"Ackaert","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2026.119128_bib89","doi-asserted-by":"crossref","first-page":"8667","DOI":"10.1038\/s41467-024-52819-z","article-title":"Genomic surveillance reveals a dengue 2 virus epidemic lineage with a marked decrease in sensitivity to Mosnodenvir","volume":"15","author":"Bouzidi","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.119128_bib90","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1021\/acsptsci.2c00105","article-title":"Corona versus dengue: distinct mechanisms for inhibition of polyprotein processing by antiviral drugs","volume":"5","author":"Behnam","year":"2022","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.ejmech.2026.119128_bib91","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.1038\/s41467-024-50437-3","article-title":"Pan-serotype dengue virus inhibitor JNJ-A07 targets NS4A-2K-NS4B interaction with NS2B\/NS3 and blocks replication organelle formation","volume":"15","author":"Kiemel","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.119128_bib92","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/jps.3030490107","article-title":"Some aspects of the pharmacology of clemizole hydrochloride","volume":"49","author":"Finkelstein","year":"1960","journal-title":"J. Am. Pharm. Assoc."},{"key":"10.1016\/j.ejmech.2026.119128_bib93","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.antiviral.2011.01.009","article-title":"New opportunities in anti-hepatitis C virus drug discovery: targeting NS4B","volume":"90","author":"Rai","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2026.119128_bib94","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1021\/ml300090x","article-title":"Imidazo[1,2- a ]pyridines that directly interact with hepatitis C NS4B: initial preclinical characterization","volume":"3","author":"Shotwell","year":"2012","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.119128_bib95","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1128\/AAC.00070-15","article-title":"Encoded library technology screening of hepatitis C virus NS4B yields a small-molecule compound series with in vitro replicon activity","volume":"59","author":"Arico-Muendel","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.119128_bib96","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1021\/ml500521r","article-title":"Lead optimization of spiropyrazolopyridones: a new and potent class of dengue virus inhibitors","volume":"6","author":"Zou","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.119128_bib97","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3390\/ph18030283","article-title":"Dengue virus inhibitors as potential broad-spectrum flavivirus inhibitors","volume":"18","author":"Ivanova","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2026.119128_bib98","doi-asserted-by":"crossref","first-page":"8233","DOI":"10.1128\/JVI.00855-15","article-title":"Discovery of dengue virus NS4B inhibitors","volume":"89","author":"Wang","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.ejmech.2026.119128_bib99","doi-asserted-by":"crossref","first-page":"7911","DOI":"10.1021\/jm900652e","article-title":"The medicinal chemistry of dengue fever","volume":"52","author":"Stevens","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119128_bib100","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1021\/jm401646w","article-title":"Highly potent HCV NS4B inhibitors with activity against multiple genotypes","volume":"57","author":"Phillips","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119128_bib101","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.bmcl.2014.01.075","article-title":"Discovery and structure\u2013activity relationships study of novel thieno[2,3-b]pyridine analogues as hepatitis C virus inhibitors","volume":"24","author":"Wang","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2026.119128_bib102","doi-asserted-by":"crossref","first-page":"321","DOI":"10.31083\/ph.2019.8960","article-title":"Discovery and structure-resistance relationship study of new Thieno[2,3-b] pyridine HCV NS4B inhibitors","volume":"74","author":"Xiao","year":"2019","journal-title":"Pharmazie"},{"key":"10.1016\/j.ejmech.2026.119128_bib103","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb2181","article-title":"NITD-688, a pan-serotype inhibitor of the dengue virus NS4B protein, shows favorable pharmacokinetics and efficacy in preclinical animal models","volume":"13","author":"Moquin","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejmech.2026.119128_bib104","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3390\/cells11040730","article-title":"High throughput screening targeting the dengue NS3-NS5 interface identifies antivirals against dengue, zika and west nile viruses","volume":"11","author":"Yang","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2026.119128_bib105","article-title":"Mechanistic insights into dengue virus inhibition by a clinical trial compound NITD-688","volume":"122","author":"Wang","year":"2025","journal-title":"Proc. Natl. Acad. Sci."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426005738?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426005738?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:01:44Z","timestamp":1787040104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426005738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":105,"alternative-id":["S0223523426005738"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119128","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Small molecule NS4B inhibitors for the treatment of the family Flaviviridae infection: A medicinal chemistry perspective","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119128","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119128"}}